These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37820316)
1. AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization. Busse NC; Al-Ghazi MSAL; Abi-Jaoudeh N; Alvarez D; Ayan AS; Chen E; Chuong MD; Dezarn WA; Enger SA; Graves SA; Hobbs RF; Jafari ME; Kim SP; Maughan NM; Polemi AM; Stickel JR J Appl Clin Med Phys; 2024 Feb; 25(2):e14157. PubMed ID: 37820316 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of imaging Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282 [TBL] [Abstract][Full Text] [Related]
3. Outpatient single-session yttrium-90 glass microsphere radioembolization. Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460 [No Abstract] [Full Text] [Related]
5. Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres. Ebbers SC; Kunnen B; van Nierop BJ; Bemelmans JLM; Krijger GC; Lam MGEH; Braat AJAT Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1378-1383. PubMed ID: 32435831 [TBL] [Abstract][Full Text] [Related]
6. A deep-learning-based prediction model for the biodistribution of Plachouris D; Tzolas I; Gatos I; Papadimitroulas P; Spyridonidis T; Apostolopoulos D; Papathanasiou N; Visvikis D; Plachouri KM; Hazle JD; Kagadis GC Med Phys; 2021 Nov; 48(11):7427-7438. PubMed ID: 34628667 [TBL] [Abstract][Full Text] [Related]
7. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related]
8. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867 [TBL] [Abstract][Full Text] [Related]
9. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
10. (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery. Camacho JC; Moncayo V; Kokabi N; Reavey HE; Galt JR; Yamada K; Kies DD; Williams RS; Kim HS; Schuster DM Radiographics; 2015; 35(5):1602-18. PubMed ID: 26230755 [TBL] [Abstract][Full Text] [Related]
11. Predicting the net administered activity in Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization. Ezponda A; Rodríguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672 [TBL] [Abstract][Full Text] [Related]
13. Radioembolization lung shunt estimation based on a Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259 [TBL] [Abstract][Full Text] [Related]
14. Calculation of lung mean dose and quantification of error for Lopez B; Mahvash A; Lam MGEH; Kappadath SC Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600 [TBL] [Abstract][Full Text] [Related]
16. Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165 [TBL] [Abstract][Full Text] [Related]
17. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039 [TBL] [Abstract][Full Text] [Related]
18. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338 [TBL] [Abstract][Full Text] [Related]
19. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954 [TBL] [Abstract][Full Text] [Related]
20. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]